Navigation Links
Early Trial of New HIV Drug Shows Promise

Promising results of a new HIV drug has raised the prospect of an effective new treatment against the deadly disease in which the immune system begins to fail. //

The drug 'raltegravir' was given for about 10 years to at least 178 patients with advanced HIV who were not responding to regular anti-retroviral HIV drugs.

The amount of HIV genetic material (RNA) in the blood of the patients was measured after 24 weeks of treatment with their usual HIV drugs plus either raltegravir or a dummy drug.

Patients taking raltegravir had an average of 98 percent drop in their HIV RNA count, compared to just 45 percent drop in the placebo group.

The number of CD4 cells, which give an indication of the immune response, were also significantly boosted in patients taking raltegravir. And the drug was well tolerated by most patients.

"This drug has the potential to become an important component of combination treatment regimens... for patients failing current therapies with multi-drug-resistant virus and limited treatment options," study authors led by Bach-Yen Nguyen of Merck Research Laboratories in Pennsylvania said.

The researchers are hopeful that the new family of drugs will get round the problem of treatment-resistant HIV strains, reported the online edition of BBC News.


Page: 1

Related medicine news :

1. Early detection of prostate cancer
2. Early detection of heart attack
3. Early puberty linked to nutrition
4. Early Clue to Down Syndrome
5. Early delivery can prevent cancer
6. Early puberty more resistance
7. Early menopause- The cause
8. Early menopause- The cause
9. Early Warning System For Breast Cancer
10. Early therapy aids eyesight
11. Early detection of colorectal cancer may be hindered by coloured toilet disinfectants
Post Your Comments:

(Date:11/24/2015)... UT (PRWEB) , ... November 24, 2015 , ... It ... Magazine. For a business, it is critical that the first impression be positive and ... they are not likely to buy anything or want to return. They will also ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... their knowledge and experiences at a live taping of the next CURE ... the Cure of Gastrointestinal Cancers 2015 Symposium at Georgetown University Hotel & Conference ...
(Date:11/24/2015)... ... ... Aided by seed funding from the Ron Foley Foundation, researchers at Western ... how to detect and treat pancreatic cancer (PC). , WCHN researchers will focus ... (ncRNA), genetic material that is present in the blood of patients with PC. ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... its exceptional customer service: the TrustDale certification. The award recognizes good companies for ... stone honing , tile and grout, and hard surface restoration company earned this ...
(Date:11/24/2015)... ... November 24, 2015 , ... World Patent Marketing ... a household invention that revolutionizes the vending machine industry by providing healthy and ... worth $2 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015  Boston Scientific Corporation (NYSE: ... Oppenheimer 26th Annual Healthcare Conference on December 8, in ... Susie Lisa , vice president, Investor Relations, will participate ... beginning at approximately 8:35 a.m. ET. --> ... in a 30-minute question-and-answer session with the host analyst ...
(Date:11/24/2015)...   Renowned UAE ... s advice and insights on supplements and healthy diet ... 50% of Dubai residents are not ...   femMED launches comprehensive solutions for women , ... residents are not consuming enough to keep themselves healthy. A local ...
(Date:11/24/2015)... 2015 Abaxis, Inc. (NasdaqGS: ABAX ), ... for the medical, research, and veterinary markets worldwide, announced ... will present at the 27 th Annual Piper ... 11:30 a.m. ET. The conference will be held at ... York City . Abaxis, Inc. is ...
Breaking Medicine Technology: